JPMorgan Chase & Co’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58K | Sell |
|
|||||
|
2025
Q1 | $18.3K | Sell |
|
|||||
|
2024
Q4 | $78K | Buy |
|
|||||
|
2024
Q3 | $12.3K | Buy |
|
|||||
|
2024
Q2 | $22.3K | Sell |
|
|||||
|
2024
Q1 | $29.6K | Sell |
|
|||||
|
2023
Q4 | $40.1K | Sell |
|
|||||
|
2023
Q3 | $53.6K | Buy |
|
|||||
|
2023
Q2 | $42K | Buy |
|
|||||
|
2023
Q1 | $8K | Buy |
|
|||||
|
2022
Q4 | $8K | Sell |
|
|||||
|
2022
Q3 | $16K | Buy |
|
|||||
|
2022
Q2 | $11K | Sell |
|
|||||
|
2022
Q1 | $64K | Buy |
|
|||||
|
2021
Q4 | $91K | Buy |
|
|||||
|
2021
Q3 | $220K | Buy |
|
|||||
|
2021
Q2 | $197K | Buy |
|
|||||
|
2021
Q1 | $273K | Sell |
|
|||||
|
2020
Q4 | $1.75M | Buy |
|